NO20082365L - Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on - Google Patents

Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on

Info

Publication number
NO20082365L
NO20082365L NO20082365A NO20082365A NO20082365L NO 20082365 L NO20082365 L NO 20082365L NO 20082365 A NO20082365 A NO 20082365A NO 20082365 A NO20082365 A NO 20082365A NO 20082365 L NO20082365 L NO 20082365L
Authority
NO
Norway
Prior art keywords
preparation
thiazolo
pyrimidin
amino
new method
Prior art date
Application number
NO20082365A
Other languages
English (en)
Inventor
Stephen E Webber
Tingmin Wang
John S Ng
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of NO20082365L publication Critical patent/NO20082365L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av tittelforbindelsen, 5-amino-3H-tiazolo[4,5-d]pyrimidin-2-on, som er et anvendelig mellomprodukt ved fremstilling av visse tiazolo[4,5-d]pyrimidin-nukleosider, som kan ha nytte som immunmodulerende midler.
NO20082365A 2005-11-21 2008-05-26 Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on NO20082365L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73805505P 2005-11-21 2005-11-21
PCT/US2006/061111 WO2007062355A2 (en) 2005-11-21 2006-11-20 PROCESS FOR THE PREPARATION OF 5-AMINO-3H- THIAZOLO [4 , 5 -d] PYRIMIDIN- 2 -ONE

Publications (1)

Publication Number Publication Date
NO20082365L true NO20082365L (no) 2008-08-18

Family

ID=37908057

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082365A NO20082365L (no) 2005-11-21 2008-05-26 Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on

Country Status (18)

Country Link
US (1) US7781581B2 (no)
EP (1) EP1973920B1 (no)
JP (1) JP5117391B2 (no)
KR (1) KR20080090400A (no)
CN (1) CN101365705A (no)
AR (1) AR058210A1 (no)
AT (1) ATE474842T1 (no)
AU (1) AU2006318260B2 (no)
BR (1) BRPI0618789A2 (no)
CA (1) CA2630463C (no)
DE (1) DE602006015700D1 (no)
EA (1) EA200801404A1 (no)
ES (1) ES2345904T3 (no)
IL (1) IL191568A0 (no)
NO (1) NO20082365L (no)
SG (1) SG152296A1 (no)
TW (1) TWI383987B (no)
WO (1) WO2007062355A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008016518A (es) 2006-06-22 2009-01-19 Anadys Pharmaceuticals Inc Profarmacos de 5-amino-3-(3'-desoxi-beta-d-ribofuranosil)-tiazolo[ 4,5-d]pirimidin-2,7-dion.
JPWO2012102366A1 (ja) * 2011-01-28 2014-06-30 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
CN103012284A (zh) * 2012-12-26 2013-04-03 无锡捷化医药科技有限公司 一种2-氨基-5-溴嘧啶类化合物的制备方法
CA2963717C (en) 2014-12-08 2023-10-10 F. Hoffmann-La Roche Ag 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
EP3568400B1 (en) 2017-01-06 2025-11-19 F. Hoffmann-La Roche AG Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
CN111635368B (zh) * 2020-06-12 2021-06-29 东莞市东阳光仿制药研发有限公司 一种胺化合物的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539205A (en) 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4746651A (en) 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5166141A (en) 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US5011828A (en) 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
GB8712745D0 (en) 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US5041426A (en) 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
US4880784A (en) 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US5041542A (en) 1988-06-03 1991-08-20 Nucleic Acid Research Institute Substituted pyrimido[5,4-d]pyrimidine nucleosides
GB9015914D0 (en) 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9105899D0 (en) 1991-03-20 1991-05-08 Wellcome Found Therapeutic nucleosides
AU5165793A (en) 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
US5395937A (en) 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5994321A (en) 1993-12-20 1999-11-30 Aronex Pharmaceuticals, Inc. Antiviral guanine analogs
US5446045A (en) 1993-12-20 1995-08-29 Revankar; Ganapathi R. Antiviral guanine analogs
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
ATE283855T1 (de) 1996-07-03 2004-12-15 Sumitomo Pharma Neue purinderivate
ATE271063T1 (de) 1996-10-16 2004-07-15 Icn Pharmaceuticals Purin-l-nukleoside, deren analoga und verwendungen
US6509320B1 (en) 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
KR100518903B1 (ko) 1996-10-25 2005-10-06 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 Ｔｈ2 매개 질병 및 관련 질병의 치료용 면역 반응 조절 화합물
NZ504800A (en) 1997-11-28 2001-10-26 Sumitomo Pharma 6-Amino-9-benzyl-8-hydroxy-purine derivatives and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases thereof
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
WO1999051608A1 (en) * 1998-04-03 1999-10-14 Du Pont Pharmaceuticals Company THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
US6444652B1 (en) 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6664260B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Heterocyclic ether substituted imidazoquinolines
US20020086871A1 (en) 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
US7157465B2 (en) 2001-04-17 2007-01-02 Dainippon Simitomo Pharma Co., Ltd. Adenine derivatives
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
EA008380B1 (ru) 2001-11-27 2007-04-27 Анадис Фармасьютикалз, Инк. 3-β-D-РИБОФУРАНОЗИЛТИАЗОЛО[4,5-d]ПИРИМИДИННУКЛЕОЗИДЫ И ИХ ПРИМЕНЕНИЯ
AU2003232071A1 (en) 2002-05-06 2003-11-17 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis c virus infection
US7196090B2 (en) * 2002-07-25 2007-03-27 Warner-Lambert Company Kinase inhibitors
WO2005016235A2 (en) 2003-04-14 2005-02-24 The Regents Of The University Of California Combined use of impdh inhibitors with toll-like receptor agonists
MXPA05013434A (es) * 2003-06-12 2006-03-17 Astellas Pharma Inc Derivados de benzamida o sal del mismo.
EP1667694B1 (en) 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Tlr7 ligands for the treatment of hepatitis c
US20050250820A1 (en) * 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity
JP2008516978A (ja) 2004-10-15 2008-05-22 バイエル・フアーマシユーチカルズ・コーポレーシヨン 肥満症の処置のためのビフェニル−４−イル−カルボニルアミノ酸誘導体の製造および使用
CN102504001B (zh) * 2004-12-17 2015-02-25 安那迪斯药品股份有限公司 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
EP1888575A2 (en) 2005-05-09 2008-02-20 Hydra Biosciences, Inc. Compounds for modulating trpv3 function
MX2008016518A (es) 2006-06-22 2009-01-19 Anadys Pharmaceuticals Inc Profarmacos de 5-amino-3-(3'-desoxi-beta-d-ribofuranosil)-tiazolo[ 4,5-d]pirimidin-2,7-dion.
WO2008011406A2 (en) 2006-07-18 2008-01-24 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines

Also Published As

Publication number Publication date
TWI383987B (zh) 2013-02-01
BRPI0618789A2 (pt) 2016-08-30
WO2007062355A2 (en) 2007-05-31
IL191568A0 (en) 2008-12-29
AR058210A1 (es) 2008-01-23
CA2630463C (en) 2015-01-06
KR20080090400A (ko) 2008-10-08
AU2006318260B2 (en) 2012-05-17
JP2009516709A (ja) 2009-04-23
EP1973920A2 (en) 2008-10-01
ES2345904T3 (es) 2010-10-05
ATE474842T1 (de) 2010-08-15
CA2630463A1 (en) 2007-05-31
SG152296A1 (en) 2009-05-29
DE602006015700D1 (de) 2010-09-02
EP1973920B1 (en) 2010-07-21
US7781581B2 (en) 2010-08-24
JP5117391B2 (ja) 2013-01-16
AU2006318260A1 (en) 2007-05-31
WO2007062355A3 (en) 2007-07-26
US20070117979A1 (en) 2007-05-24
TW200736265A (en) 2007-10-01
CN101365705A (zh) 2009-02-11
EA200801404A1 (ru) 2008-10-30

Similar Documents

Publication Publication Date Title
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
NO20081133L (no) Tieno[2,3-B]-pyridin-5-karbonitriler som protein kinase inhibitorer
WO2007023110A3 (en) P38 map kinase inhibitors and methods for using the same
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
WO2005021536A3 (en) Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
EA200801381A1 (ru) Производные пиримидина
CL2007003459A1 (es) Proceso de preparacion de compuestos derivados de pirimidina; y compuesto intermediario (s)-trans-etil 3-etoxi-7-(4-(4-fluorofenil)-6-isopropil-2-(n-metilmetilsulfonamido)pirimidin-5-il)-5-hidroxihep-2,6-dienoato.
NO20082365L (no) Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on
WO2007079199A3 (en) Substituted bis-amide metalloprotease inhibitors
WO2009006389A8 (en) Pyrimidine derivatives useful as raf kinase inhibitors
WO2007041130A3 (en) Deazapurines useful as inhibitors of janus kinases
NO20075232L (no) Fremgangsmate for fremstilling av pyrido[2,3-d]pyrimidin-7-on og 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1 H)-on derivater
WO2007092095A3 (en) [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
WO2008066558A3 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
WO2005076990A3 (en) Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
WO2006087120A8 (de) Pyrazolopyrimidine
WO2007070613A3 (en) Rifamycin analogs and uses thereof
EA200802248A1 (ru) Способы применения соединений 4-амино-5-хлортиено[2,3-d]-пиримидина в качестве инсектицидов
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer
WO2007070463A3 (en) Compositions, methods and kits for removing debris from an ocular area
WO2005018627A8 (en) Alpha-aminoamide derivatives useful as anti-inflammatory agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application